The Association Between Antiepileptic Drugs and Bone Disease

Overview

Journal Epilepsy Curr

Publisher Sage Publications

Date 2004 Aug 17

PMID 15309069

Citations 28

Authors

Alison M Pack

Affiliations

Soon will be listed here.

Abstract

A growing body of literature indicates an association between antiepileptic drugs (AEDs) and bone disease, including histologic, radiographic, and biochemical evidence. The AEDs most commonly reported to cause decreased bone mineral density and disorders of bone metabolism are inducers of the cytochrome P450 enzyme system (phenobarbital, phenytoin, carbamazepine, primidone). More recent studies also suggest that valproate, an enzyme inhibitor, causes abnormalities in bone health. Multiple mechanisms have been postulated to support the association; however, no single mechanism explains all the findings. Identifying bone disease in persons with epilepsy receiving AEDs is important, as multiple treatment options are available.

Citing Articles

Effects of One-Year Anti-seizure Treatment with Add-On Cenobamate on Bone Density and Bone Turnover in Adults with Drug-Resistant Focal Epilepsy: An Observational Study.

Novitskaya Y, Schulze-Bonhage A, Schutz E, Hirsch M CNS Drugs. 2024; 39(1):95-106.

PMID: 39638959 PMC: 11695382. DOI: 10.1007/s40263-024-01137-5.

Vitamin D content and prevalence of vitamin D deficiency in patients with epilepsy: a systematic review and meta-analysis.

Liu Y, Gong C, Li J, Ning X, Zeng P, Wang L Front Nutr. 2024; 11:1439279.

PMID: 39279896 PMC: 11392846. DOI: 10.3389/fnut.2024.1439279.

Proportion of Hidden Vertebral Fractures Among Egyptian Males With Fragility Hip Fractures in the Emergency Room of Ain Shams University Hospitals.

Abbas A, Allam M, Sweed H, Abdul-Rahman S, Ali W Cureus. 2024; 15(12):e49960.

PMID: 38179371 PMC: 10765554. DOI: 10.7759/cureus.49960.

Understanding Lamotrigine's Role in the CNS and Possible Future Evolution.

Costa B, Vale N Int J Mol Sci. 2023; 24(7).

PMID: 37047022 PMC: 10093959. DOI: 10.3390/ijms24076050.

A Mini Review on Osteoporosis: From Biology to Pharmacological Management of Bone Loss.

Chin K, Ng B, Rostam M, Muhammad Fadzil N, Raman V, Mohamed Yunus F J Clin Med. 2022; 11(21).

PMID: 36362662 PMC: 9657533. DOI: 10.3390/jcm11216434.

References

Kafali G, Erselcan T, Tanzer F . Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12 years. Clin Pediatr (Phila). 1999; 38(2):93-8. DOI: 10.1177/000992289903800205. View

Akin R, Okutan V, Sarici U, Altunbas A, Gokcay E . Evaluation of bone mineral density in children receiving antiepileptic drugs. Pediatr Neurol. 1998; 19(2):129-31. DOI: 10.1016/s0887-8994(98)00039-3. View

Jaglal S, Kreiger N, Darlington G . Lifetime occupational physical activity and risk of hip fracture in women. Ann Epidemiol. 1995; 5(4):321-4. DOI: 10.1016/1047-2797(94)00100-8. View

Davie M, Emberson C, LAWSON D, Roberts G, Barnes J, Barnes N . Low plasma 25-hydroxyvitamin D and serum calcium levels in institutionalized epileptic subjects: associated risk factors, consequences and response to treatment with vitamin D. Q J Med. 1983; 52(205):79-91. View

Chesnut 3rd C, Silverman S, Andriano K, Genant H, Gimona A, Harris S . A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group. Am J Med. 2000; 109(4):267-76. DOI: 10.1016/s0002-9343(00)00490-3. View

Collins N, Maher J, Cole M, Baker M, Callaghan N . A prospective study to evaluate the dose of vitamin D required to correct low 25-hydroxyvitamin D levels, calcium, and alkaline phosphatase in patients at risk of developing antiepileptic drug-induced osteomalacia. Q J Med. 1991; 78(286):113-22. View

Brown A, Dusso A, Slatopolsky E . Vitamin D. Am J Physiol. 1999; 277(2):F157-75. DOI: 10.1152/ajprenal.1999.277.2.F157. View

Vernillo A, Rifkin B, Hauschka P . Phenytoin affects osteocalcin secretion from osteoblastic rat osteosarcoma 17/2.8 cells in culture. Bone. 1990; 11(5):309-12. DOI: 10.1016/8756-3282(90)90085-d. View

Ettinger B, Black D, Mitlak B, Knickerbocker R, Nickelsen T, Genant H . Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA. 1999; 282(7):637-45. DOI: 10.1001/jama.282.7.637. View

10.

Leblanc A, Evans H, Marsh C, Schneider V, Johnson P, JHINGRAN S . Precision of dual photon absorptiometry measurements. J Nucl Med. 1986; 27(8):1362-5. View

11.

DENT C, Richens A, Rowe D, Stamp T . Osteomalacia with long-term anticonvulsant therapy in epilepsy. Br Med J. 1970; 4(5727):69-72. PMC: 1819593. DOI: 10.1136/bmj.4.5727.69. View

12.

Gough H, Bissesar A, Goggin T, Higgins D, Baker M, Crowley M . Factors associated with the biochemical changes in vitamin D and calcium metabolism in institutionalized patients with epilepsy. Ir J Med Sci. 1986; 155(6):181-9. DOI: 10.1007/BF02939839. View

13.

Stephen L, McLellan A, Harrison J, Shapiro D, Dominiczak M, Sills G . Bone density and antiepileptic drugs: a case-controlled study. Seizure. 1999; 8(6):339-42. DOI: 10.1053/seiz.1999.0301. View

14.

Bouillon R, Reynaert J, Claes J, Lissens W, DE MOOR P . The effect of anticonvulsant therapy on serum levels of 25-hydroxy-vitamin D, calcium, and parathyroid hormone. J Clin Endocrinol Metab. 1975; 41(06):1130-5. DOI: 10.1210/jcem-41-6-1130. View

15.

Timperlake R, Cook S, Thomas K, Harding A, Bennett J, HALLER J . Effects of anticonvulsant drug therapy on bone mineral density in a pediatric population. J Pediatr Orthop. 1988; 8(4):467-70. DOI: 10.1097/01241398-198807000-00017. View

16.

Richens A, Rowe D . Disturbance of calcium metabolism by anticonvulsant drugs. Br Med J. 1970; 4(5727):73-6. PMC: 1819609. DOI: 10.1136/bmj.4.5727.73. View

17.

Weinstein R, Bryce G, Sappington L, King D, GALLAGHER B . Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment. J Clin Endocrinol Metab. 1984; 58(6):1003-9. DOI: 10.1210/jcem-58-6-1003. View

18.

Harden C, Pulver M, Ravdin L, Jacobs A . The effect of menopause and perimenopause on the course of epilepsy. Epilepsia. 1999; 40(10):1402-7. DOI: 10.1111/j.1528-1157.1999.tb02012.x. View

19.

Perucca E . Clinical implications of hepatic microsomal enzyme induction by antiepileptic drugs. Pharmacol Ther. 1987; 33(1):139-44. DOI: 10.1016/0163-7258(87)90042-8. View

20.

Chung S, Ahn C . Effects of anti-epileptic drug therapy on bone mineral density in ambulatory epileptic children. Brain Dev. 1994; 16(5):382-5. DOI: 10.1016/0387-7604(94)90125-2. View